Express Pharma

Mankind partners with ace turtle for omnichannel transformation

Ace turtle will enable Mankind Pharma with a Unified Commerce Platform that supports various omnichannel use cases and drive customer experience at scale across digital channels, informed a company statement

0 773

Mankind Pharma has partnered with ace turtle, an omnichannel platform company to accelerate its omnichannel transformation in India. A statement informed, “Ace turtle will enable Mankind Pharma with a Unified Commerce Platform that supports various omnichannel use cases and drive seamless customer experience at scale across digital channels.”

Speaking on the partnership, Joy Chatterjee, General Manager, Mankind Pharma said “At Mankind Pharma, we endeavour to continuously improve customer experience by providing them high quality and affordable products. To consistently deliver the omnichannel experiences that customers expect, we needed to create a strong foundation of technology building blocks. We are happy to partner with ace turtle as their highly scalable solution will play a critical role in accelerating our omnichannel strategy”.

A company statement informed, “Powered by machine learning, ace turtle’s Unified Commerce Platform, Rubicon 3.0 supports various omnichannel use cases such as inventory lying anywhere can be sold across channels, fulfilling orders from any stock points (retail stores, warehouses, and distributors) and a single view of product, inventory, and customer through a single platform.”

Speaking on the partnership, Nitin Chhabra, CEO, ace turtle said “Our partnership with Mankind is a milestone. Mankind Pharma understands the needs of the customers and develops superior quality products at affordable prices. We are delighted to be associated with the brand known for serving life in India. We are confident that our omnichannel platform Rubicon will improve Mankind Pharma’s business performance and build flexibility against future disruptions”.

- Advertisement -

Leave A Reply

Your email address will not be published.